FDx Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,626
Closed -$254K 813
2020
Q4
$254K Buy
+1,626
New +$209K 0.01% 619
2020
Q2
Sell
-3,055
Closed -$274K 637
2020
Q1
$274K Buy
3,055
+1,048
+52% +$103K 0.02% 406
2019
Q4
$217K Buy
+2,007
New +$215K 0.01% 572
2018
Q4
Sell
-1,623
Closed -$226K 867
2018
Q3
$226K Sell
1,623
-792
-33% -$99.3K 0.01% 795
2018
Q2
$300K Sell
2,415
-7,663
-76% -$896K 0.01% 726
2018
Q1
$1.12M Sell
10,078
-569
-5% -$68K 0.03% 468
2017
Q4
$1.27M Buy
10,647
+33
+0.3% +$4.02K 0.03% 467
2017
Q3
$1.49M Sell
10,614
-668
-6% -$90.8K 0.04% 412
2017
Q2
$1.37M Buy
11,282
+366
+3% +$42.6K 0.04% 430
2017
Q1
$1.32M Sell
10,916
-4,720
-30% -$609K 0.04% 427
2016
Q4
$1.91M Sell
15,636
-582
-4% -$71.2K 0.06% 294
2016
Q3
$1.99M Buy
16,218
+4,322
+36% +$556K 0.08% 211
2016
Q2
$1.39M Buy
11,896
+1,994
+20% +$283K 0.06% 276
2016
Q1
$1.38M Sell
9,902
-621
-6% -$91.2K 0.06% 278
2015
Q4
$2.01M Buy
10,523
+2,574
+32% +$450K 0.09% 187
2015
Q3
$1.24M Buy
7,949
+1,432
+22% +$261K 0.11% 195
2015
Q2
$1.18M Buy
6,517
+4,317
+196% +$745K 0.06% 291
2015
Q1
$373K Buy
2,200
+41
+2% +$7.42K 0.01% 1109
2014
Q4
$399K Buy
+2,159
New +$400K 0.02% 626

Other funds holding ALXN